|Free Dividend Report|
|Stock Splits Calendar|
|APDN Stock Split History|
|Preferred Stock Newsletter|
|APDN Options Chain|
|Stock Message Boards|
Applied DNA Sciences (APDN) has 1 split in our APDN split history database. The split for APDN took place on November 01, 2019. This was a 1 for 40 reverse split, meaning for each 40 shares of APDN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 25 share position following the split.
When a company such as Applied DNA Sciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the APDN split history from start to finish, an original position size of 1000 shares would have turned into 25 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Applied DNA Sciences shares, starting with a $10,000 purchase of APDN, presented on a split-history-adjusted basis factoring in the complete APDN split history.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||13.15%|
|About Applied DNA Sciences|
|Applied DNA Sciences develops and markets DNA-based technology solutions utilizing its LinearDNA polymerase chain reaction (PCR) based manufacturing platform. Co.'s proprietary platform produces DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes applications. In addition, Co. has developed a PCR-based molecular diagnostic test for COVID-19. Co. manufactures and sells its Emergency Use Authorization authorized COVID-19 molecular diagnostic test kit under the Linea COVID-19 Assay Kit trademark. According to our APDN split history records, Applied DNA Sciences has had 1 split.|
|APDN Split History Table|
|11/01/2019||1 for 40|
|Industrials Stock Splits|
|APDN is categorized under the Industrials sector; below are some other companies in the same sector that also have a history of stock splits:
Also explore: APDN shares outstanding history